Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FUQPK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,019
Award facts
- Contract value 100% obligated
- $60,018.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $60,018.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens. This non-competitive, competitively awarded delivery order is scheduled for completion by September 23, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a prescription biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma, making this procurement a critical pharmaceutical supply for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a broad range of medications and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency, demonstrating its capability to meet federal requirements for specialized pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FUQPK?
SPE2DB25FUQPK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FUQPK worth?
The government has obligated $60,019 on SPE2DB25FUQPK.
Is contract SPE2DB25FUQPK an order under another contract?
Yes. SPE2DB25FUQPK is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUQPK competed?
The extent of competition for SPE2DB25FUQPK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award